Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2781 publications
Lymphocyte Dynamics and the Emergence of Secondary Autoimmunity Following Immune Reconstitution Therapies in Multiple Sclerosis.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: October 17, 2025
Expert consensus opinion on the management of hairy cell leukemia in elderly patients.
Journal: Leukemia & lymphoma
Published: October 10, 2025
IRIS without PML in MS patients - a case report of IRIS after past alemtuzumab therapy with subsequent oral cladribine treatment and review of the literature.
Journal: Annals of agricultural and environmental medicine : AAEM
Published: September 30, 2025
Threading through the data for chemotherapy-free alternatives in the treatment of hairy cell leukemia.
Journal: Leukemia & lymphoma
Published: September 01, 2025
Adolescent-and-Young-Adult-Onset Multisystem Langerhans Cell Histiocytosis With Central Nervous System Involvement: A Case Report.
Journal: Cureus
Published: August 25, 2025
Updates on immunosuppressant safety and malignancy risk in patients with multiple sclerosis.
Journal: Expert opinion on drug safety
Published: August 20, 2025
Efficacy and safety of Cladribine as a therapeutic option in multiple sclerosis patients over 50 years of age: A real-world study.
Journal: Journal of the neurological sciences
Published: August 11, 2025
Precision oncology to overcome resistance in R/R AML in children and adults requires combinations of cytotoxic, targeted, and immunological treatments.
Journal: Journal of internal medicine
Published: August 08, 2025
Evaluation of the effect of highly effective multiple sclerosis disease-modifying drugs on the progression of the disease using diffusion-weighted magnetic resonance imaging with tractography
Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
Published: August 08, 2025
COVID-19 Vaccine Boosters in People With Multiple Sclerosis: Improved SARS-CoV-2 Cross-Variant Antibody Response and Prediction of Protection.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: July 22, 2025
A drug evaluation narrative review of cladribine as a treatment for multiple sclerosis.
Journal: Neurodegenerative disease management
Published: July 21, 2025
Last Updated: 10/31/2025